New hope for Tough-to-Treat lung cancer patients
Disease control
Recruiting now
This study is testing whether adding an experimental drug called nelmastobart to standard chemotherapy (docetaxel) can help control advanced lung cancer. It's for patients whose cancer has continued to grow despite previous treatments like platinum-based chemotherapy or immunothe…
Phase: PHASE2 • Sponsor: STCube, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC